Gene Signature for High-Risk Form of Acute Lymphoblastic Leukemia Identified by CHOP Scientists
In treating T-ALL, certain drugs work for some patients who relapse, but these drugs are not effective for all patients who relapse.
In treating T-ALL, certain drugs work for some patients who relapse, but these drugs are not effective for all patients who relapse.
Loss-of-function mutations in LTBR result in a stromal defect, leading to dysfunctional secondary lymphoid organs and combined immunodeficiency in humans.
Oxford Nanopore Technologies observes that direct analysis has already enhanced research across species, disease states, and applications.
Despite the dazzle of its spectral capabilities, flow cytometry is helping users focus on their research, clinical, and diagnostic applications.
The relative lengths of your fingers might be linked to your alcohol consumption patterns.
The announcement comes about four months after Musk relayed his vision for patients with an Optimus robotic arm or leg to have the ability to…
If confirmed, physician and former congressman David Weldon would helm an agency dealing with communication challenges and a battered image
Konyang University Hospital, one of South Korea’s designated centres for safe health data access and use for research, is increasing AI deployments to harness big…
Providers are rapidly adopting generative AI-based clinical documentation tools to aid clinicians and make digital paperwork more efficient. | Cambridge Health Alliance, the only public…
After 60 years, scientists know why gingers, calicos, and tortoiseshells look the way they do
Researchers hope findings will lead to new class of drugs for many different diseases for which proteolethargy is a common denominator.